Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00582
|
|||||
| Drug Name |
Hyperforin
|
|||||
| Synonyms |
(+)-Hyperforin; (1R,5S,6R,7S)-4-hydroxy-5-isobutyryl-6-methyl-1,3,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione; (1R,5S,6R,7S)-4-hydroxy-6-methyl-1,3,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)-5-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione; CHEMBL1237210; CHEMBL501711; GTPL2764; HSDB 7646; Hyperforin, > Hyperforine; RM741E34FP; SCHEMBL15557965; SCHEMBL98723; Spectrum5_002025; UNII-RM741E34FP; hiperforina
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C35H52O4
|
|||||
| Canonical SMILES |
CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C
|
|||||
| InChI |
InChI=1S/C35H52O4/c1-22(2)13-12-19-33(11)27(16-14-23(3)4)21-34(20-18-25(7)8)30(37)28(17-15-24(5)6)31(38)35(33,32(34)39)29(36)26(9)10/h13-15,18,26-27,37H,12,16-17,19-21H2,1-11H3/t27-,33+,34+,35-/m0/s1
|
|||||
| InChIKey |
KGSZHKRKHXOAMG-HQKKAZOISA-N
|
|||||
| CAS Number |
CAS 11079-53-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 536.8 | Topological Polar Surface Area | 71.4 | ||
| Heavy Atom Count | 39 | Rotatable Bond Count | 11 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
9.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
119525335
, 135069160
, 135652691
, 136920433
, 137129265
, 162222084
, 162249902
, 163512518
, 163687927
, 164811059
, 198951052
, 223740124
, 226474246
, 240497415
, 250133007
, 252467756
, 26756467
, 26758917
, 32961534
, 36885170
, 48334623
, 48407595
, 53789375
, 57269580
, 57403622
, 77566771
, 9810
|
|||||
| ChEBI ID |
ChEBI:5834
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
